A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.

Clinical trial NCT07559175 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07559175
Sponsor: Aimmune Nestlé Health Science US R&D, LLC
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Exocrine Pancreatic Insufficiency (EPI)Cystic Fibrosis (CF)Pancreatic Enzyme Abnormality Pancreatic Diseases

Start date: 2026-04-01
Primary completion: 2027-06-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.